Colgate Palmolive CO Form 4 insider transactions

Colgate-Palmolive Director Brian Newman acquired stock units valued at $89.05 each as part of a deferred compensation plan.

John P. Bilbrey, a Director at Colgate-Palmolive, acquired company stock through a deferred compensation plan.

Colgate-Palmolive Chief Growth Officer John Hazlin reported the vesting of performance-based restricted stock units and a subsequent sale of shares to cover tax liabilities.

Colgate-Palmolive's Chief Legal Officer and Secretary, Jennifer Daniels, reported the vesting of performance-based restricted stock units and subsequent tax-related share withholding.

Colgate-Palmolive's EVP and Controller, Gregory Malcolm, increased his direct beneficial ownership of company common stock through the vesting of performance-based restricted stock units.

Colgate-Palmolive's Chief Human Resources Officer, Sally Massey, reported the vesting of performance-based restricted stock units and subsequent tax-related share withholding.

Colgate-Palmolive's CFO, Stanley J. Sutula III, reported the vesting of performance-based restricted stock units and subsequent tax-related share withholding.

Colgate-Palmolive's COO, Panagiotis Tsourapas, reported the vesting of 25,742 performance-based restricted stock units and the disposition of 13,081 shares for tax purposes.

Colgate-Palmolive CEO Noel R. Wallace reported the vesting of 136,710 performance-based restricted stock units and the subsequent disposition of 68,252 shares for tax obligations.

Colgate-Palmolive's COO, Panagiotis Tsourapas, exercised stock options and subsequently sold a portion of the acquired common stock.

Colgate-Palmolive's EVP and Controller, Malcolm Gregory, exercised stock options and subsequently sold a portion of the acquired shares.

Colgate-Palmolive's Chief Human Resources Officer, Sally Massey, exercised stock options and subsequently sold shares on February 5, 2026.

Colgate-Palmolive's Chief Financial Officer, Stanley J. Sutula III, exercised stock options and subsequently sold 97,843 shares of common stock.

Colgate-Palmolive's Chief Legal Officer and Secretary, Jennifer Daniels, exercised stock options and subsequently sold an equal number of shares.

Colgate-Palmolive Chairman, President & CEO Noel R. Wallace sold 45,568 shares of common stock for approximately $4.28 million under a Rule 10b5-1 plan.

Colgate-Palmolive Director John P. Bilbrey acquired 301 shares of common stock by deferring a portion of his annual cash retainer.

Colgate-Palmolive Director Brian Newman acquired 238 shares of common stock at $78.66 per share through a deferred compensation plan.

Colgate-Palmolive Director Lorrie M. Norrington acquired 333 shares of common stock by deferring a portion of her annual cash retainer.

Colgate-Palmolive Chairman, President & CEO Noel R. Wallace reported a planned disposition of 1,307 common shares for tax obligations on December 3, 2025.

Colgate-Palmolive's COO, Panagiotis Tsourapas, reported a future disposition of 221 common shares on December 3, 2025, to cover tax obligations from restricted stock units.

Colgate-Palmolive's Chief Financial Officer, Stanley J. Sutula III, disposed of 385 shares of common stock to cover tax liabilities from restricted stock units.

Colgate-Palmolive's EVP and Controller, Gregory Malcolm, disposed of 41 shares of common stock valued at $78.2 per share to cover tax liabilities from restricted stock units.

Colgate-Palmolive's Chief Growth Officer, John Hazlin, reported a routine disposition of 156 common shares for tax withholding purposes.

Colgate-Palmolive's Chief Legal Officer and Secretary, Jennifer Daniels, disposed of 213 shares of common stock to cover tax liabilities from restricted stock units.

Colgate-Palmolive's Chief Human Resources Officer, Sally Massey, reported the sale of 1,237 shares of common stock for $80.89 per share.

Colgate-Palmolive Director Brian Newman acquired 228 shares of common stock by deferring a portion of his annual cash retainer.

Colgate-Palmolive Director Lorrie M Norrington acquired 319 shares of common stock by deferring a portion of her annual cash retainer.

Colgate-Palmolive Co. Director John P. Bilbrey acquired 289 shares of common stock through a deferred compensation plan.

Colgate-Palmolive's CLO and Secretary, Jennifer Daniels, disposed of 1,421 shares of common stock to cover tax liabilities from restricted stock unit vesting.

Colgate-Palmolive's Chief Growth Officer, John Hazlin, disposed of 826 shares of common stock to cover tax liabilities related to restricted stock unit vesting.